MUCOLYTIC AGENTS FOR USE IN TRETAING PULMONARY SARCOIDOSIS.

• 1. 用于治疗肺结节病的粘液溶解剂 [P] . 中国专利： CN107249621A . 2017-10-13
• 2. 用于治疗粘液高分泌的含有粘液溶解剂的组合物及其给药装置 [P] . 中国专利： CN112533589A . 2021-03-19
• 3. MUCOLYTIC AGENTS FOR USE IN TRETAING PULMONARY SARCOIDOSIS [P] . 欧洲知识产权局专利： EP3191090A2 . 2017-07-19

  机译： 用于治疗肺结节病的糖酵解剂

• 4. MUCOLYTIC AGENTS FOR USE IN TRETAING PULMONARY SARCOIDOSIS [P] . IN201717012364A . 2017-07-14

  机译： 用于治疗肺结节病的糖酵解剂

• 5. Mucolytic agents for use in tretaing pulmonary sarcoidosis [P] . AU2015315455A1 . 2017-04-27

  机译： 用于治疗肺结节病的粘液溶解剂

• 1. Randomized Control Trial on the Efficacy of Dual Bronchodilator of Glycopyrronium/Indacaterol for Lung Cancer Surgery: Improvement of Postoperative Pulmonary Function in Both Patients with Chronic Obstructive Pulmonary Disease and Normal Pulmonary Function [J] . Takanori Ayabe, Masaki Tomita, Ryo Maeda, 外科学（英文） . 2020,第006期
• 2. The dynamic study of the pulmonary artery obstruction degree and the right ventricular function in massive pulmonary embolism on CT pulmonary angiography [J] . Jianguo Wang, Yulin Guo, Xiaojuan Guo, 生物医学研究杂志（英文版） . 2008,第003期
• 3. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD). [J] . Davies L, Calverley PM British Medical Bulletin . 2010,第Null期
• 4. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD) [J] . L. Davies, P. M. A. Calverley British Medical Bulletin . 2010,第1期
• 5. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye [J] . Xiangzhe Li, Boram Kang, In Ho Woo, Investigative ophthalmology & visual science . 2018,第7期
• 6. The Effects of Mucolytic Agents on Transport Rates of Nanoparticles in Human CF Sputum [C] . Controlled Release Society annual meeting . 2004
• 7. An investigation of potential protection by spin trapping agents against amiodarone-induced pulmonary toxicity. [D] . Comeau, Jeannette Louise. 2006
• 8. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine carbocysteine and N-acetylcysteine [O] . Paola Rogliani, Maria Gabriella Matera, Clive Page, 2019
• 9. ПОРІВНЯЛЬНИЙ АНАЛІЗ ПРОФІЛЮ ЕФЕКТИВНОСТІ ТА БЕЗПЕКИ ЕРДОСТЕЇНУ, КАРБОЦИСТЕЇНУ ТА N-АЦЕТИЛЦИСТЕЇНУ ПРИ ХРОНІЧНОМУ ОБСТРУКТИВНОМУ ЗАХВОРЮВАННІ ЛЕГЕНЬ (за матеріалами статті Rogliani P, Matera MG, Page C, et al. Efficacy and safety profile of mucolytic/ antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respiratory Research. 2019;20:104) [O] . S. I. Leshchenko 2020
• 10. Noninvasive Diagnosis of Pulmonary Embolism: Positive Image Scanning Agent for Pulmonary Embolism [R] . Parkhill, B. J., Parkey, R. W., Wilson, J. E., 1981

• 1. Effect of pronase as mucolytic agent on imaging quality of magnifying endoscopy [J] . Gwang Ha Kim ,Yu Kyung Cho ,Jae Myung Cha . 世界胃肠病学杂志：英文版 . 2015,第8期
• 2. Previous Pulmonary Fibrosis in Dermatomyositis/Polymyositis: A Predictive Factor for Pulmonary and Extra-Pulmonary Tuberculosis [J] . Taysa Cristiane Moreira da Silva ,Adriana Coracini Tonacio de Proenca ,Samuel Katsuyuki Shinjo . 风湿病与自身免疫疾病期刊（英文） . 2018,第4期
• 3. Anatomy features and surgical significance of pulmonary circuits of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries [J] . 方敏华 . 外科研究与新技术 . 2011,第3期
• 4. 一种可用于胆固醇型结石溶解的新型溶石剂 [C] . 刘微 ,LIU Wei ,ZHANG Chao . 第十七届全国分子光谱学学术会议 . 2012
• 5. 改性麦草吸附剂用于水中溶解性有机氮去除的行为研究 [A] . 张晓晓 . 2014